NANS Knockout HAP1 Cell Line

The choice depends on whether you are studying NANS (N-acetylneuraminic acid synthase)'s role in de novo sialic acid biosynthesis or modeling NANS-related congenital disorder of glycosylation. The Knockout line is the standard tool for asking whether NANS is required for cellular sialic acid generation — NANS condenses N-acetylmannosamine 6-phosphate with phosphoenolpyruvate to generate N-acetylneuraminic acid 9-phosphate, the rate-limiting step of Neu5Ac biosynthesis. Overexpression is useful for studying NANS in heterologous expression contexts. For glycobiology research, the EDITGENE NANS Knockout in HAP1 enables study of sialic acid biosynthesis. NANS deficiency causes Camera-Genevieve syndrome (NANS-CDG), a congenital disorder of glycosylation with intellectual disability and skeletal dysplasia — disease variant rescue enables genotype-function studies. Rescue with wild-type NANS or exogenous sialic acid supplementation enables comprehensive characterization. The knockout is valuable for studying sialylation-dependent processes including viral receptor function and immune signaling.

Primary applications: • Cellular sialic acid quantification: total Neu5Ac (free and protein/lipid-conjugated) measurement by HPLC or LC-MS in NANS-null cells. • Sialylation status: surface sialylated glycan staining (e.g., MAA, SNA lectin binding) by flow cytometry to assess overall cellular sialylation in the absence of de novo Neu5Ac synthesis. • NANS-CDG modeling: rescue with patient-derived NANS mutations for genotype-function studies of congenital disorder of glycosylation. • Sialylation-dependent processes: viral receptor binding (influenza HA recognizes sialylated glycans), selectin-mediated leukocyte adhesion studies. EDITGENE recommends this model for researchers investigating sialic acid biosynthesis, sialylation-dependent biology, and NANS-CDG mechanisms.

Yes. NANS rescue experiments are well-established for sialic acid biology research: • Construct design: use a codon-modified NANS sequence with a small C-terminal tag (FLAG, HA). NANS has N-terminal AFP-like and C-terminal SIS catalytic domains — preserve both. • Catalytically-dead rescue: active site residue mutations abolish Neu5Ac synthase activity and serve as the standard specificity control. • NANS-CDG mutation rescue: patient-derived NANS mutations enable disease genotype-function studies. • Sialic acid supplementation control: NANS-CDG patients are treated with exogenous Neu5Ac supplementation — this can serve as a metabolic 'rescue' independent of genetic rescue. • Functional readout: rescue should restore cellular Neu5Ac levels and surface sialylation. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.